Tosei Corporation Enhances Corporate Governance

TipRanksApr 26 02:17 ET

The clinical trial of Dongcheng Pharmaceutical (002675.SZ)'s subsidiary GA-LNC1007 injection was approved by the Health Sciences Board of Singapore

Dongcheng Pharmaceutical (002675.SZ) issued an announcement. On April 9, 2024, the company's subsidiary company LNC P...

Zhitong FinanceApr 10 04:31 ET

Tosei Corporation Unveils Quarterly Financials

TipRanksApr 10 02:17 ET

Tosei's Profit Balloons 46% in Q1 of Fiscal 2024

Tosei (TYO:8923) recorded a 45.7% rise in attributable profit for the three months ended Feb. 29 to 6.44 billion yen from 4.42 billion yen during the year-ago period, a Friday filing on the Japan bour

MT NewswiresApr 5 06:09 ET

Tosei Corp 1Q Net Y6.44B Vs Net Y4.42B

Tosei Corp. (8923.TO) Japan 1st Quarter Ended February 29 GROUP 2024 2023 Revenue Y34.87 bln Y31.05 bln Operating Profit Y9.59 bln Y6.78

Dow JonesApr 5 02:00 ET

Tosei Included in GPIF ESG Benchmark

Tosei Corp. (TYO:8923) has been included in the Government Pension Investment Fund's (GPIF) newly adopted ESG investment benchmark, the MSCI Nihonkabu ESG Select Leaders Index, according to its Monday

MT NewswiresMar 18 21:48 ET